Harnessing C1q in Ophthalmic Neurodegenerative Diseases

• Elucidating the role of C1q in ophthalmic neurodegenerative diseases
• Integrating preclinical and clinical data to validate C1q’s impact on neurodegeneration
• Leveraging advanced imaging for longitudinal assessment of neurodegenerative progression and therapeutic response

Speakers:

Lori Taylor

Senior Vice President, Portfolio Strategy & Operations

Annexon Biosciences